Intuitive Surgical’s (NASDAQ: ISRG) primary headwinds are its high valuation and slowing growth. The combination has weighed on price action since early 2025 and is unlikely to go away soon. However, the high valuation today prices in a solid growth outlook, ultimately undervaluing the company’s potential.
Intuitive Surgical’s potential is the dominance of robotic surgical procedures. The company has a first-mover advantage, with an installed base of over 12,000 devices and growing. In this scenario, the 45X valuation relative to current year earnings is only a small hurdle, given the potential for a 50% or greater stock price increase over the next few years.
